To gain insights into the mechanisms underlying NK-mediated resistance to ICB, we analyzed the cellular composition of NRAS;Ink4a and YUMM5.2 melanomas across cohorts by scRNA-seq (Supplementary Fig. S9A and S9B; Supplementary Table S10). The gene discussed is CDKN2A; the disease is melanoma.